“We are not cash rich right now. We're not in a position where we can do large a...
Eric Tokat, biotech’s most prolific dealmaker, believes 2024 will be another str...
Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months...
Boston Scientific said it will buy Axonics, a device company tackling urinary an...
Lilly's plan to offer its Zepbound weight-loss drug directly may make it easier ...
Johnson & Johnson said Monday it would purchase Ambrx Biopharma for nearly $2 bi...
Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of ...
The VC firm has hired Jeff Jonas, Sage’s former chief executive, and Al Robichau...
Stacy Sanders will be HHS' first chief competition officer, a position created a...
Backed by Mayo Clinic and Microsoft, a new nonprofit venture will oversee a nati...
Americans are obsessed with health and fitness tracking. It’s time for a data diet.
Cost isn’t the only reason why Medicare doesn’t cover weight loss drugs.
STAT readers weigh in on inhalable epinephrine as an alternative to EpiPens, nut...
The Biden administration approved Florida Gov. Ron DeSantis’ plan to import a li...
By discontinuing the brand-name Flovent inhaler but continuing to earn money fro...
Today's Readout newsletter: Allogene changes gears, Illumina exec leaves to beco...
